The Manitoba Medical Service Foundation gratefully acknowledges the generosity and support of corporate partners who have helped fund research grants contributing to furthering research in Manitoba by supporting health through research. Listed are current and previous partners to the Foundation.
Manitoba Blue Cross (MBC)
Manitoba Blue Cross (MBC) is the primary contributor, both in funds and administrative support for the MMSF, enabling the Foundation to provide funds for the advancement of scientific, educational and other activities in the maintenance and improvement of the health and welfare of the residents of Manitoba. Since 1971 Manitoba Blue Cross has provided over $7,508,000 to the Foundation in capital and grant contributions, as well as providing annual administration costs.
As leaders in the provision of supplementary health care for all Manitobans, Manitoba Blue Cross has a legacy of strong community ties that have made a positive impact for over forty years. MBC is proud of their past support and energized to continue to be architects of strong individuals, groups and communities across our Province for the years to come. Manitoba Blue Cross is a sturdy supporter of many initiatives including the United Way, Scholarship Programs and the Children’s Wish Foundation. Please take the time to visit the MBC website to discover more about the Colour of Caring and the depths MBC goes to achieve this goal.
The St. Boniface Hospital Research Centre (SBRC)
The MMSF (Manitoba Medical Service Foundation) and the SBRC (St. Boniface Hospital Research Centre) cooperatively sponsor the Richard Hoeschen Memorial Award. This award is provided annually in the name of Richard Hoeschen to commemorate his creative and innovative spirit. The SBRC and MMSF have provided support towards this award since 2005. The award is currently valued at up to $4,000 annually with half of the award contributed by each organization. These contributions are approved annually by the respective Boards and to date the combined contributions total $40,000. The MMSF is proud to continue partnering with the SBRC.
The Winnipeg Foundation (WF)
Between 2005 and 2013, The Winnipeg Foundation (WF) partnered with the Manitoba Medical Service Foundation (MMSF) to fund over $375,000 in grants to further health research. The MMSF is proud to continue partnering with The Winnipeg Foundation.
The Relationship Between Concussion and Academic Performance Among Manitoba Students in Grades 9-12. $11,000 (MMSF) $10,000 (WF)
Assessment of Oral Health in Youth With Type 2 Diabetes Mellitus. $15,000 (MMSF) $10,000 (WF)
Multilevel Analysis of Risk Factors for Youth Homicide and Severe Intentional Injury in Winnipeg. $10,000 (MMSF) $10,000 (WF)
Novel Strategy Improving the Proportion of Inactive Older Adults who Reach the Canadian Physical Activity Guidelines to Improve Health and Physical Capacity. $10,000 (MMSF) $10,000 (WF)
Return to work barriers to returning to work among cancer survivors: A population-based study of survivors of common cancers. $10,000 (MMSF) $10,000 (WF)
Imagining oneself as a physically active person as a means of increasing current physical activity self-view and physical activity behaviour. $10,000 (MMSF) $10,000 (WF)
Effects of behavioural intervention on brain plasticity in Children with Autism. $7,500 (MMSF) $12,500 (WF)
Mental and physical health correlates of physical punishment and the relationship between physical punishment and family violence: Data from a nationally representative sample.
$7,500 (MMSF) $12,500 (WF)
Does geography influence the treatment and outcomes of colorectal cancer in the Province of Manitoba? $12,500 (MMSF) $12,500 (WF)
Hormone use, estrogen receptor expression, and survival of women with non-small cell lung cancer: A Manitoba perspective. $12,500 (MMSF) $12,500 (WF)
Decision making in the acquired brain injury triad: Perspectives of persons with acquired brain injury, their families and professionals. $25,000 (MMSF) $19,500 (WF)
Differences in vaginal health after hysterectomy with and without retention of the cervix.
$22,500 (MMSF) $12,500 (WF)
Benefits of exercise in prostate cancer survivors receiving androgen depletion therapy.
$22,500 (MMSF) $12,500 (WF)
It's Safe to Ask: Evaluating the Impact of a Provincial Health Literacy and Communication Initiative. $25,000 (WF)
Assessment of Patient Satisfaction, Outcomes and Waiting Times in Women Who Present to the Early Pregnancy Assessment Clinic. $20,250 (WF)
Manitoba Institute of Child Health (MICH)
Since 2008, the Manitoba Medical Service Foundation and the Manitoba Institute of Child Health have co-funded twelve grants totalling $320,000. This partnership proudly continues, enabling our organizations to forward health-related research in Manitoba.
Mechanical Modulation of Transforming Growth Factor Beta Responses in Airway Smooth Muscle Cells. $10,000 (MMSF) $10,000 (MICH)
Investigating the Physiological Function of Uncoupling Protein 2 in Pancreatic Beta Cells and its Contribution to Type 2 Diabetes Development: An In Vivo Approach $12,500 (MMSF) $12,500 (MICH)
Neonatal Chronic Lung Disease in Double-Hit Rat Model Induced by Postnatal Hyperoxia and Intermittent Hypoxia: Closer to Clinical Features? $10,000 (MMSF) $10,000 (MICH)
Molecular Regulation of Insulin Sensitivity During Skeletal Muscle Differentiation. $10,000 (MMSF) $10,000 (MICH)
How often are antibiotics prescriptions filled after children are discharged from hospital? $10,000 (MMSF) $10,000 (MICH)
New approach to gene therapy for the GM2 gangliosidoses. $11,500 (MMSF) $11,500 (MICH)
Characteristics of DNA modification in identical twins with different chorion types. $11,500 (MMSF) $11,500 (MICH)
The perinatal determinants of congenital anomalies of the kidney and urinary tract. $11,000 (MMSF) $11,000 (MICH)
MeCP2 and neuronal differentiation of embryonic stem cells. $10,000 (MMSF) $10,000 (MICH)
The association between maternal selective serotonin re-uptake inhibitor (SSRI) use in late pregnancy and neonatal respiratory disorders with a focus on persistent pulmonary hypertension of the newborn. $2,500 (MMSF) $12,500 (MICH)
Role of epigenetics in normal and abnormal pulmonary development due to congenital diaphragmatic hernia. $7,500 (MMSF) $12,500 (MICH)
Phenotypic and genotypic characterization of patients with Ritscher-Schinzel Syndrome. $12,500 (MMSF) $12,500 (MICH)
Combining clinic data on fetal alcohol spectrum disorder (FASD) with administrative data on health, education and social services. $12,500 (MMSF) $12,500 (MICH)
Screening for developmental delay in young children. $10,000 (MMSF) $10,000 (MICH)
Travel-related illnesses in pediatric travellers who visit friends and relatives abroad (TIP-VFRs). $11,000 (MMSF) $11,000 (MICH)
The Victoria General Hospital Foundation (VGHF)
During 2013, the VGHF agreed to participate in a joint granting partnership for the MMSF 2013 Competition for Funds, and together with the MMSF jointly funded one grant totalling $22,000. THE MMSF thanks the VGHF for the cooperative funding partnership in 2013 and congratulates the VGHF on continuing to fulfil their mission to enhance patient care at the Victoria General Hospital. The VGHF raises funds for innovative medical equipment, research, education, and capital projects.
The Impact of a Pre-Operative Exercise Program on Fitness Outcomes Follwing Bariatric Surgery. $11,000 (MMSF) $11,000 (VGHF)
The Manitoba Health Research Council (MHRC)
In 2009, the MMSF and the MHRC formed an agreement to fund Clinical Research Professorships at the University of Manitoba. Jointly funded are the MMSF/MHRC Dr. F. W. Du Val Clinical Research Professorship (previously named the Dr. F. W. Du Val Clinical Research Professorship) and the MMSF/MHRC Clinical Research Professorship in Population Medicine (previously named the Clinical Research Professorship in Population Medicine). In 2011 the MMSF/MHRC Clinical Research Professorship in Population Medicine was renamed the MMSF/MHRC John Henson Clinical Research Professorship in Population Medicine. Together the MMSF and the MHRC cooperatively funded four clinical research professorships. The MMSF and MHRC continue to work together to promote the development and retention of clinical research and researchers in Manitoba. See Professorships for more details on these awards and awardees.
Manitoba Medical College Foundation
A new Home for the Manitoba Medical College Foundation (MMCF)
In 2011 the MMCF decided to wind down its operations and partnered with The Winnipeg Foundation (WF) to steward the 60 funds under its care. The MMCF played an important role in the healthcare community supporting innovative research and medical students. Now, through The Winnipeg Foundation the funds continue to grow, honoring the donor’s legacies.
Our partnership with the MMCF enabled our foundations to cooperatively fund almost $50,000 in research grants. Below are listed the grants that were cooperatively funded between our organizations.
Magnetic nanoparticles for enhanced drug delivery to the brain. $25,000 (MMCF)
Enhancing Clot-Busting Medication in Stroke with Directed Drug Convection Using Magnetic Nano-Particles. $4,872 (MMSF) $20,000 (MMCF)
The Health Sciences Centre Foundation (HSCF)
During 2009, the HSCF agreed to participate in a joint granting partnership for the 2009 Competition, and together with the MMSF jointly funded grants totalling $50,000. The MMSF thanks the HSCF for the cooperative funding partnership in 2009 and congratulates HSCF on the great research they continue to support through their foundation.
Quetiapine, as a novel therapeutics in Alzheimer's disease. $10,000 (MMSF) $15,000 (HSCF)
A randomized double-blinded, placebo-controlled, cross-over trial assessing the effect of tadalafil (Cialis) on the cardiovascular response in men with complete spinal cord injury at or above the sixth thoracic level. $10,000 (MMSF) $15,000 (HSCF)
The University of Manitoba - Office of the Vice President (Research)
The MMSF and the University of Manitoba – Office of the Vice President (Research) formed an alliance for the 2009 Competition; wherein the University provided funds for one non-medical research grant.
Bioavailability studies of selected components of flaxseed in plasma of patients with peripheral arterial disease (PAD). $10,000 (MMSF) $15,000 (U of M)
Continue reading the next page: Funding and Revenue History